by Sharon Rondeau (Jan. 29, 2021) — On Monday the FDA announced it would “limit use” of two types of monoclonal antibodies to fight COVID-19, which some criticized as a decision made without any supporting “clinical data.” “As we have throughout the COVID-19 pandemic, the U.S. Food and Drug Administration has used the best available […]